Cite
HARVARD Citation
Rossotti, R. et al. (2020). Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. Journal of infection. 81 (4), pp. e11-e17. [Online].